© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

SRI

Top section

Top section

Adnoc expands sustainable financing with $2bn green loan

The company's new loan is backed by a Korean export credit agency
By backing too many speculative IPOs, investment banks could threaten the whole market
SSA

IDB Invest becomes first MDB to tap its securitization

$450m add-on makes deal more efficient

Finland's YIT signs €200m SLL and amends term loan

Company retains same roster of banks that provided last loan
By backing too many speculative IPOs, investment banks could threaten the whole market
Sub-sections
  • Bond market participants fear that the G20 common framework for debt relief risks doing more harm than good. The warning came this week as confusion regarding the private sector’s role in Ethiopia’s proposed use of the framework dented government bonds across sub-Saharan Africa. The lack of clarity must be quickly rectified to avoid lasting contagion in African bond markets, market participants said. Mariam Meskin and Oliver West report.
  • Three African issuers entered debt markets this week and raised cash at competitive levels, despite a difficult external backdrop of debt relief in the region and continued US rates weakness.
  • UK biotech firms are continuing to reap the benefits from US listings. On Tuesday Autolus Therapeutics, an early stage biopharma firm backed by Syncona Investments, became the latest UK Biotech firm to raise capital on the US Nasdaq in a $100m transaction. The deal shows the continued advantages for early stage European biotech firms in having a US listing.